Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.

Eitemau Tebyg

• Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
  gan: Bayer, A S, et al.
  Cyhoeddwyd: (1988)
• Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
  gan: Bayer, A S, et al.
  Cyhoeddwyd: (1986)
• Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
  gan: Hirano, L, et al.
  Cyhoeddwyd: (1991)
• Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
  gan: Bayer, A S, et al.
  Cyhoeddwyd: (1987)
• Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.
  gan: Godfrey, A J, et al.
  Cyhoeddwyd: (1984)